Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate-to-severe psoriasis: results from the PRISTINE trial

Author:

Thaçi D.1,Galimberti R.2,Amaya-Guerra M.3,Rosenbach T.4,Robertson D.5,Pedersen R.5,Yang S.6,Kuligowski M.6,Boggs R.6

Affiliation:

1. Excellence Center for Inflammation Medicine; University Hospital Schleswig-Holstein; University of Lübeck; Lübeck Germany

2. Hospital Italiano de Buenos Aires; Buenos Aires Argentina

3. Servicios Médicos de la Universidad Autonóma de Nuevo León; Monterrey Mexico

4. Dermatology Clinic Rosenbach and Partner; Osnabrück Germany

5. Pfizer Inc; Collegeville PA USA

6. Formerly of Pfizer Inc; Collegeville PA USA

Funder

Wyeth

Pfizer Inc

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Reference30 articles.

1. National Psoriasis Foundation About Psoriasis http://www.psoriasis.org/about-psoriasis

2. Medical comorbidity associated with psoriasis in adults: a population-based study;Yang;Br J Dermatol,2011

3. Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study;Dauden;J Eur Acad Dermatol Venereol,2009

4. Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis;Reich;Dermatology,2009

5. Psoriasis: cardiovascular risk factors and other disease comorbidities;Wu;J Drugs Dermatol,2008

Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3